MannKind Corp (MNKD)
4.205
+0.02
(+0.36%)
USD |
NASDAQ |
Apr 25, 14:12
MannKind Gross Profit (Quarterly): 40.40M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 40.40M |
September 30, 2023 | 37.00M |
June 30, 2023 | 34.37M |
March 31, 2023 | 24.41M |
December 31, 2022 | 19.94M |
September 30, 2022 | 15.36M |
June 30, 2022 | 5.979M |
March 31, 2022 | 0.994M |
December 31, 2021 | 1.081M |
September 30, 2021 | 12.32M |
June 30, 2021 | 13.35M |
March 31, 2021 | 9.826M |
December 31, 2020 | 12.16M |
September 30, 2020 | 10.18M |
June 30, 2020 | 9.454M |
March 31, 2020 | 8.709M |
December 31, 2019 | 8.972M |
September 30, 2019 | 5.66M |
June 30, 2019 | 8.536M |
March 31, 2019 | 11.89M |
December 31, 2018 | 9.969M |
September 30, 2018 | -0.834M |
June 30, 2018 | -1.202M |
March 31, 2018 | -0.543M |
December 31, 2017 | -0.488M |
Date | Value |
---|---|
September 30, 2017 | -2.532M |
June 30, 2017 | -2.923M |
March 31, 2017 | 0.461M |
December 31, 2016 | -2.034M |
September 30, 2016 | 135.22M |
June 30, 2016 | -4.045M |
March 31, 2016 | -5.168M |
December 31, 2015 | -49.06M |
September 30, 2015 | -8.115M |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.994M
Minimum
Mar 2022
40.40M
Maximum
Dec 2023
14.67M
Average
10.18M
Median
Sep 2020
Gross Profit (Quarterly) Benchmarks
Cassava Sciences Inc | -- |
NovaBay Pharmaceuticals Inc | 1.815M |
Palatin Technologies Inc | 1.936M |
iBio Inc | -- |
Theriva Biologics Inc | -- |